4.6 Article

The learning curve associated with laparoscopic total gastrectomy

Journal

GASTRIC CANCER
Volume 19, Issue 1, Pages 264-272

Publisher

SPRINGER
DOI: 10.1007/s10120-014-0447-y

Keywords

Learning curve; Laparoscopic total gastrectomy; Stomach neoplasms

Ask authors/readers for more resources

Although the frequency of laparoscopic total gastrectomy (LTG) has been increasing, the procedure requires considerable experience because of its technical difficulty and the concern for oncological safety. This study intended to define the learning curve associated with the procedure. All 256 cases of LTG performed from June 2003 to December 2012 were enrolled. The cases were divided into ten groups of 25 cases based on when they occurred. The learning curve was defined using the moving average method. LTG, performed in the absence of other procedures (pure-LTG, 132 cases), was extracted from the ten groups, and the mean operative time and estimated blood loss (EBL) were compared to define the learning curve. Retrieved lymph nodes, hospital stay, and complications were compared across the phases of the learning curve. LTG with spleen resection, performed in the absence of other procedures (pure-srLTG, 53 cases), was also analyzed by the same method. A three-phase learning curve of LTG was defined: the first two groups, the following two groups, and the final six groups (mean operative time: 223.0, 244.8, and 207.8 min, respectively, p = 0.003; mean EBL: 94.6, 237.0, and 116.5 ml, respectively, p < 0.001). The rates of complications and open conversions were similar across the three phases. There were no significant differences in mean operative time, EBL, retrieved LNs, hospital stay, or complication rates between pure-LTG and pure-srLTG, after completing the respective learning curves. Experience with approximately 100 LTG cases was required to complete learning of the procedure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Postoperative pain and quality of life after single-incision distal gastrectomy versus multiport laparoscopic distal gastrectomy for early gastric cancer - a randomized controlled trial

So Hyun Kang, Mira Yoo, Duyeong Hwang, Eunju Lee, Sangjun Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Hyung-Ho Kim

Summary: This study compared the postoperative outcomes and patient quality of life between single-incision distal gastrectomy (SIDG) and multiport laparoscopic distal gastrectomy (MLDG). The results showed no significant difference in postoperative pain scores, hospital stay, and postoperative QOL between the two groups.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)

Article Gastroenterology & Hepatology

Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease

Ho Soo Chun, Minjong Lee, Hye Ah Lee, Sejin Lee, Soyeon Kim, Ye Jun Jung, Chaewon Lee, Hyoeun Kim, Han Ah Lee, Hwi Young Kim, Kwon Yoo, Tae Hun Kim, Sang Hoon Ahn, Seung Up Kim

Summary: This study aimed to determine the relationship between sarcopenic obesity (SO) and the risk of significant liver fibrosis or cardiovascular disease (CVD) in nonalcoholic fatty liver disease (NAFLD). Through a multicenter retrospective study, it was found that high-risk subjects with SO had a higher risk of liver fibrosis and CVD development. The results demonstrated that high-risk subjects with SO had significantly increased risks of liver fibrosis and CVD development.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Medicine, General & Internal

Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma

Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim

Summary: In this study, the association between long-term statin use and hepatocellular carcinoma (HCC) recurrence after surgery for hepatitis B virus (HBV)-related HCC was assessed. The study found that long-term statin use was significantly associated with reduced risk of HCC recurrence and liver-related mortality.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Gastroenterology & Hepatology

Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma

Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim

Summary: This study compared the outcomes of sorafenib and nivolumab as second-line agents after failed lenvatinib treatment in patients with advanced HCC. The results showed that lenvatinib-sorafenib sequential treatment resulted in significantly better survival than lenvatinib-nivolumab sequential treatment.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Medicine, General & Internal

Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study

Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim

Summary: This study aimed to compare the postoperative recurrence of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV)-infected HCC who received antiviral therapy (AVT) compared to those who did not. The results showed that the recurrence rates of HCC were similar between AVT users and non-users with detectable serum HBV-DNA, regardless of the presence of liver cirrhosis. Therefore, initiating AVT based on detectable serum HBV-DNA can provide a similar risk of postoperative HCC recurrence.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Oncology

Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers

Yujun Park, Soo Kyung Nam, Soo Hyun Seo, Kyoung Un Park, Hyeon Jeong Oh, Young Suk Park, Yun-Suhk Suh, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee

Summary: In this study, PCR-based MSI testing and IHC for MMR protein expression were comprehensively analyzed and compared in gastric cancer patients. Among the 5,676 cases, the majority were microsatellite stable/MSI-low, while a small percentage showed MSI-high and loss of MLH1 expression. Re-evaluation of discordant/indeterminate cases revealed the need for complementary testing in order to improve accuracy.

JOURNAL OF GASTRIC CANCER (2023)

Correction Oncology

Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years (vol 23, pg 1051, 2020)

Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sang-Hoon Ahn, Do Joong Park, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Dong Ho Lee, Hyung-Ho Kim

GASTRIC CANCER (2023)

Article Gastroenterology & Hepatology

Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients

Du Hyun Song, Nayoung Kim, Hyeong Ho Jo, Sangbin Kim, Yonghoon Choi, Hyeon Jeong Oh, Hye Seung Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, So Hyun Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Jin Won Kim, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn, Young-Joon Surh

Summary: This study aimed to identify risk factors for synchronous multiple gastric cancer (SMGC). Data from 14,603 patients with gastric cancer were analyzed, and the incidence of SMGC was found to be 4.04%, which was associated with male sex, age ≥65 years, and early gastric cancer. Unlike single gastric cancer, SMGC had a high survival rate.

GUT AND LIVER (2023)

Article Gastroenterology & Hepatology

Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease

Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon

Summary: This study investigated the effects of nonalcoholic fatty liver disease (NAFLD) on the outcome of inflammatory bowel disease (IBD) patients. The results showed that the presence of NAFLD may increase the risk of clinical relapse in patients with IBD. Additionally, the study found that hepatic steatosis was significantly associated with increased risks of clinical relapse in patients with ulcerative colitis and Crohn's disease, while fibrotic burden in the liver was not.

GUT AND LIVER (2023)

Article Gastroenterology & Hepatology

CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B

Hye Yeon Chon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, Sang Hoon Ahn, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Lilian Yan Liang, In Hee Kim, Grace Lai-Hung Wong, Seung Up Kim

Summary: This study compared the predictive accuracy of three risk prediction models for hepatocellular carcinoma (HCC) development after 5 years of antiviral therapy in patients with chronic hepatitis B. The results showed that the SAGE-B and CAGE-B models might be better than the PAGE-B model in predicting HCC development after 5 years of treatment.

JOURNAL OF DIGESTIVE DISEASES (2023)

Article Gastroenterology & Hepatology

Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis

David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim

Summary: This study validated the predictive performance of the CHESS-ALARM model in patients with HBV-related liver cirrhosis and compared it with other TE-based models. The results showed that CHESS-ALARM had similar predictive performance as LSPS, PH, varices risk scores, ALBI, and ALBI-FIB-4.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study

Eugene Han, Ho Soo Chun, Yong-ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Seung Up Kim

Summary: The risks of sarcopenia and cardiovascular disease (CVD) are significantly higher in metabolic dysfunction-associated fatty liver disease (MAFLD) group compared to non-metabolic risk (MR) non-alcoholic fatty liver disease (NAFLD) group. However, the risk does not differ according to fibrotic burden in non-MR NAFLD group. The MAFLD criteria might be better for identifying high-risk fatty liver disease than the NAFLD criteria.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Surgery

Postoperative major bleeding risk in patients using oral antiplatelets and/or anticoagulants after laparoscopic gastric cancer surgery

Chami Im, Young Suk Park, Sa-Hong Min, So Hyun Kang, Sangjun Lee, Eunju Lee, Mira Yoo, Duyeong Hwang, Sang-Hoon Ahn, Yun Suhk Suh, Do Joong Park, Hyung-Ho Kim

Summary: This study investigated the association between antiplatelet and/or anticoagulant therapies and the risk of postoperative major bleeding in laparoscopic gastric cancer surgery. The study found that preoperative use of antiplatelets and/or anticoagulants did not significantly increase the risk of postoperative major bleeding.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2023)

Article Surgery

Standard follow-up after curative surgery for advanced gastric cancer: secondary analysis of a multicentre randomized clinical trial (KLASS-02)

Sin Hye Park, Woo Jin Hyung, Han-Kwang Yang, Young-Kyu Park, Hyuk-Joon Lee, Ji Yeong An, Wook Kim, Hyoung-Il Kim, Hyung-Ho Kim, Seung Wan Ryu, Hoon Hur, Min-Chan Kim, Seong-Ho Kong, Gyu Seok Cho, Jin-Jo Kim, Do Joong Park, Young-Woo Kim, Jong Won Kim, Joo-Ho Lee, Sang-Uk Han, Keun Won Ryu

Summary: The study did not find any survival benefit from regular follow-up after radical gastrectomy for gastric cancer, and it suggests the need for a prospective randomized controlled trial to determine the survival benefit.

BRITISH JOURNAL OF SURGERY (2023)

No Data Available